Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess Safety, Tolerability, and Pharmacokinetics of NHL907 Combination Drug Following Multiple Oral Doses in Healthy Adult Participants

NCT07580924 is registered in ClinicalTrials.gov with NeuHyll AUS Pty Ltd as lead sponsor.

NCT NCT07580924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07580924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess Safety, Tolerability, and Pharmacokinetics of NHL907 Combination Drug Following Multiple Oral Doses in Healthy Adult Participants
Lead sponsor
NeuHyll AUS Pty Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
May 12, 2026
Completion date
April 30, 2027
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult participants